{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:01:04Z","timestamp":1793239264649,"version":"4.5.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We developed a novel immunoradiometric assay (IRMA; whole parathyroid hormone [PTH] IRMA) for PTH, which specifically measures biologically active whole PTH(1\u201384). The assay is based on a solid phase coated with anti-PTH(39\u201384) antibody, a tracer of125I-labeled antibody with a unique specificity to the first N-terminal amino acid of PTH(1\u201384), and calibrators of diluted synthetic PTH(1\u201384). In contrast to the Nichols intact PTH IRMA, this new assay does not detect PTH(7\u201384) fragments and only detects one immunoreactive peak in chromatographically fractionated patient samples. The assay was shown to have an analytical sensitivity of 1.0 pg\/ml with a linear measurement range up to 2300 pg\/ml. With this assay, we further identified that the previously described non-(1\u201384)PTH fragments are aminoterminally truncated with similar hydrophobicity as PTH(7\u201384), and these PTH fragments are present not only in patients with secondary hyperparathyroidism (2\u00b0-HPT) of uremia, but also in patients with primary hyperparathyroidism (1\u00b0-HPT) and normal persons. The plasma normal range of the whole PTH(1\u201384) was 7\u201336 pg\/ml (mean \u00b1 SD: 22.7 \u00b1 7.2 pg\/ml, n = 135), whereas over 93.9% (155\/165) of patients with 1\u00b0-HPT had whole PTH(1\u201384) values above the normal cut-off. The percentage of biologically active whole PTH(1\u201384) (pB%) in the pool of total immunoreactive \u201cintact\u201d PTH is higher in the normal population (median: 67.3%; SD: 15.8%; n = 56) than in uremic patients (median:53.8%; SD: 15.5%; n = 318; p &amp;lt; 0.001), although the whole PTH(1\u201384) values from uremic patients displayed a more significant heterogeneous distribution when compared with that of 1\u00b0-HPT patients and normals. Moreover, the pB% displayed a nearly Gaussian distribution pattern from 20% to over 90% in patients with either 1\u00b0-HPT or uremia. The specificity of this newly developed whole PTH(1\u201384) IRMA is the assurance, for the first time, of being able to measure only the biologically active whole PTH(1\u201384) without cross-reaction to the high concentrations of the aminoterminally truncated PTH fragments found in both normal subjects and patients. Because of the significant variations of pB% in patients, it is necessary to use the whole PTH assay to determine biologically active PTH levels clinically and, thus, to avoid overestimating the concentration of the true biologically active hormone. This new assay could provide a more meaningful standardization of future PTH measurements with improved accuracy in the clinical assessment of parathyroid function.<\/jats:p>","DOI":"10.1359\/jbmr.2001.16.4.605","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T03:39:48Z","timestamp":1146109188000},"page":"605-614","source":"Crossref","is-referenced-by-count":295,"title":["Development of a Novel Immunoradiometric Assay Exclusively for Biologically Active Whole Parathyroid Hormone 1\u201384: Implications for Improvement of Accurate Assessment of Parathyroid Function"],"prefix":"10.1093","volume":"16","author":[{"given":"Ping","family":"Gao","sequence":"first","affiliation":[{"name":"Department of R & D and Diagnostics, Scantibodies Laboratory, Inc., Santee, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Scheibel","sequence":"additional","affiliation":[{"name":"Department of R & D and Diagnostics, Scantibodies Laboratory, Inc., Santee, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"D'Amour","sequence":"additional","affiliation":[{"name":"Centre de Recherche du CHUM, University of Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus R.","family":"John","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhaker D.","family":"Rao","sequence":"additional","affiliation":[{"name":"Henry Ford Hospital, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Schmidt-Gayk","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Oncology, Laboratory Group, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Cantor","sequence":"additional","affiliation":[{"name":"Department of R & D and Diagnostics, Scantibodies Laboratory, Inc., Santee, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024020714132432700_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1073\/pnas.49.5.613","article-title":"Immunoassay of bovine and human parathyroid hormone","volume":"49","author":"Berson","year":"1963","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024020714132432700_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1677\/joe.0.0730279","article-title":"Two-site assay of bovine parathyroid hormone","volume":"73","author":"Woodhead","year":"1977","journal-title":"J Endocrinol"},{"key":"2024020714132432700_bib3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcaemia","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin Chem"},{"key":"2024020714132432700_bib4","first-page":"1","volume-title":"Current clinical concept: Assessment of parathyroid function with an N-terminal specific radioimmunoassay for intact parathyroid hormone","author":"Potts","year":"1983"},{"key":"2024020714132432700_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0009-8981(95)06171-1","article-title":"Immunochemiluminometric assay with two monoclonal antibodies against the N-terminal sequence of human parathyroid hormone","volume":"245","author":"Gao","year":"1996","journal-title":"Clin Chim Acta"},{"key":"2024020714132432700_bib6","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJM197911153012005","article-title":"The peripheral metabolism of parathyroid hormone","volume":"302","author":"Martin","year":"1979","journal-title":"N Engl J Med"},{"key":"2024020714132432700_bib7","first-page":"145","article-title":"Intact parathyroid hormone over-estimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia","volume":"75","author":"Quarles","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714132432700_bib8","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ki.1993.323","article-title":"Aplastic osteodystrophy without aluminium: The role of \u201csuppressed\u201d parathyroid function","volume":"44","author":"Hercz","year":"1993","journal-title":"Kidney Int"},{"key":"2024020714132432700_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ki.1994.31","article-title":"Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD\/CCPD","volume":"45","author":"Salusky","year":"1994","journal-title":"Kidney Int"},{"key":"2024020714132432700_bib10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","article-title":"A non-(1\u201384) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples","volume":"44","author":"Lepage","year":"1998","journal-title":"Clin Chem"},{"key":"2024020714132432700_bib11","first-page":"3923","article-title":"Accumulation of a non-(1\u201384) molecular form of parathyroid (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values","volume":"81","author":"Brossard","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714132432700_bib12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.1658941","article-title":"A G protein-linked receptor for the parathyroid hormone and parathyroid hormone-related peptide","volume":"254","author":"Jueppner","year":"1991","journal-title":"Science"},{"key":"2024020714132432700_bib13","doi-asserted-by":"crossref","first-page":"15455","DOI":"10.1074\/jbc.270.26.15455","article-title":"Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor","volume":"270","author":"Usdin","year":"1995","journal-title":"J Biol Chem"},{"key":"2024020714132432700_bib14","first-page":"E886","article-title":"Peripheral metabolism of PTH: Fate of biologically active amino terminus in vivo","volume":"255","author":"Bringhurst","year":"1988","journal-title":"Am J Physiol"},{"key":"2024020714132432700_bib15","first-page":"70","article-title":"Effects of plasma calcium concentration on the metabolic clearance rates of parathyroid hormone in the dog","volume":"102","author":"Fox","year":"1983","journal-title":"J Lab Clin Med"},{"key":"2024020714132432700_bib16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1210\/jcem-66-3-495","article-title":"Recovery of parathyroid hormone secretion after parathyroid adenomectomy","volume":"66","author":"Brasier","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714132432700_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0009-8981(90)90177-T","article-title":"Two-site assay of intact parathyroid hormone in primary hyperparathyroidism: Study in basal condition, following adenoma removal and during calcium and EDTA infusion","volume":"190","author":"Mazzuoli","year":"1990","journal-title":"Clin Chim Acta"},{"key":"2024020714132432700_bib18","first-page":"79","volume-title":"Calcium Regulating Hormones and Markers of Bone Metabolism: Measurement and Interpretation","author":"Gao","year":"1997","edition":"2nd Ed."},{"key":"2024020714132432700_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/bj1970391","article-title":"Isolation and analysis of human parathyrin in parathyroid tissue and plasma","volume":"197","author":"Bennett","year":"1981","journal-title":"Biochem J"},{"key":"2024020714132432700_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/clinchem\/46.5.697","article-title":"Influence of glomerular filtration rate on non-(1\u201384) parathyroid hormone (PTH) detected by intact PTH assays","volume":"46","author":"Brossard","year":"2000","journal-title":"Clin Chem"},{"key":"2024020714132432700_bib21","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","article-title":"A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure","volume":"84","author":"John","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714132432700_bib22","first-page":"S1;S564","article-title":"Recognition of the PTH(7\u201384) fragment by 5 commercial PTH \u201csandwich\u201d assays","volume":"15","author":"Gao","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024020714132432700_bib23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0025-6196(12)60717-4","article-title":"Clinical performance of parathyroid hormone immunometric assays","volume":"67","author":"Kao","year":"1992","journal-title":"Mayo Clin Proc"},{"key":"2024020714132432700_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/clinchem\/37.2.162","article-title":"Immunochemiluminometric immunoradiometric determinations of intact and total immunoreactive parathyrin: Performance in the differential diagnosis of hypercalcemia and hypoparathyroidism","volume":"37","author":"Endres","year":"1991","journal-title":"Clin Chem"},{"key":"2024020714132432700_bib25","first-page":"S1;S167","article-title":"A new highly sensitive assay for parathyroid hormone in primary hyperparathyroidism","volume":"15","author":"Silverberg","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024020714132432700_bib26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"key":"2024020714132432700_bib27","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1210\/endo.136.11.7588200","article-title":"Characterization of a novel parathyroid hormone (PTH) receptor with specificity for the carboxyl-terminal region of PTH(1\u201384)","volume":"136","author":"Inomata","year":"1995","journal-title":"Endocrinology"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.2001.16.4.605","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/16\/4\/605\/56606287\/5650160402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/16\/4\/605\/56606287\/5650160402.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:02:36Z","timestamp":1710342156000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/16\/4\/605-614\/7516003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,1]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2001,4,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.2001.16.4.605","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2001,4,1]]},"published":{"date-parts":[[2001,4,1]]}}}